This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.10% per year. These returns cover a period from January 1, 1988 through October 7, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Analysts Estimate LyondellBasell (LYB) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
LyondellBasell (LYB) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Trade Tariffs Cloud Diversified Chemical Industry Outlook
by Anindya Barman
Diversified chemical companies are roiled by the damaging effects of U.S.-China trade tensions.
Top Ranked Income Stocks to Buy for July 24th
by Zacks Equity Research
Here are four stocks with buy rank and strong income characteristics for investors to consider today, July 24th
Is LyondellBasell (LYB) Stock Undervalued Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
LyondellBasell Expands Production in Thailand Through HMC JV
by Zacks Equity Research
The unit is slated to be the most advanced unit globally, which will use LyondellBasell's (LYB) Spherizone production technology.
LyondellBasell (LYB) Unveils Preliminary Guidance for Q2
by Zacks Equity Research
LyondellBasell (LYB) projects EPS in the range of $2.79-$2.91 for the second quarter of 2019.
LyondellBasell (LYB) and Neste Produce Bio-Based Plastics
by Zacks Equity Research
LyondellBasell's (LYB) collaboration with Neste indicates a major milestone in the commercialization of the latter's renewable polymers and chemicals business.
LyondellBasell (LYB) Looks Good: Stock Adds 5.6% in Session
by Zacks Equity Research
LyondellBasell (LYB) saw a big move last session, as its shares jumped nearly 6% on the day, amid huge volumes.
Why Is LyondellBasell (LYB) Down 12.1% Since Last Earnings Report?
by Zacks Equity Research
LyondellBasell (LYB) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
LyondellBasell's Spheripol is Chosen for PP Plant in Vietnam
by Zacks Equity Research
The Spheripol technology is selected for the PP project on the back of its strong licensing record along with the operational experience of LyondellBasell (LYB).
Air Products to Supply for POSCO Chemical's Gwangyang Site
by Zacks Equity Research
Air Products (APD) will build and operate two air separation units to support POSCO Chemical's new production line.
LyondellBasell's (LYB) Q1 Earnings Top Estimates, Sales Trail
by Anindya Barman
LyondellBasell (LYB) benefited from improved market demand in the first quarter.
LyondellBasell (LYB) Q1 Earnings Beat, Sales Miss Estimates
by Zacks Equity Research
LyondellBasell's (LYB) adjusted earnings came in at $2.22 per share for the first quarter, beating the Zacks Consensus Estimate of $2.20.
What's in the Cards for LyondellBasell (LYB) in Q1 Earnings?
by Zacks Equity Research
While LyondellBasell (LYB) faces headwinds from maintenance outages and pressure on olefin margins, it should gain from the A. Schulman buyout in Q1.
Earnings Preview: LyondellBasell (LYB) Q1 Earnings Expected to Decline
by Zacks Equity Research
LyondellBasell (LYB) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
LyondellBasell Grants Hostalen ACP License to PetroChina
by Zacks Equity Research
PetroChina's new HDPE plants to use LyondellBasell's (LYB) Hostalen ACP technology.
Is LyondellBasell Industries (LYB) a Great Stock for Value Investors?
by Zacks Equity Research
Is LyondellBasell Industries (LYB) a great pick from the value investor's perspective right now? Read on to know more.
LyondellBasell (LYB) Boosts Hostalen ACP License in China
by Zacks Equity Research
LyondellBasell's (LYB) latest Hostalen ACP line marks its 10th project licensed in China.
The Zacks Analyst Blog Highlights: DowDuPont, LyondellBasell Industries, Ingevity, Innospec and W. R. Grace
by Zacks Equity Research
The Zacks Analyst Blog Highlights: DowDuPont, LyondellBasell Industries, Ingevity, Innospec and W. R. Grace
Why a US-China Trade Pact Will be a Boon for US Chemicals
by Anindya Barman
Chemical is among the industries that have been badly hit by Sino-U.S. trade tensions.
Material ETFs Stand Tall Amid Weak Q4 Earnings
by Sweta Killa
Basic materials is one of the weakest sectors this reporting cycle. But, it was unable to take the sheen away from material ETFs that are up nearly 1% over the past week.
LyondellBasell's (LYB) Q4 Earnings & Revenues Lag Estimates
by Zacks Equity Research
LyondellBasell's (LYB) Q4 earnings hurt by decline in crude oil prices along with unusual operational events.
LyondellBasell (LYB) Earnings & Sales Miss Estimates in Q4
by Zacks Equity Research
LyondellBasell's (LYB) adjusted earnings per share of $1.83 in Q4 missed the Zacks Consensus Estimate of $2.13.
Can LyondellBasell (LYB) Sustain Earnings Streak in Q4?
by Anindya Barman
LyondellBasell's (LYB) operational improvement initiatives and A. Schulman buyout are expected to drive results in Q4.
Celanese (CE) to Report Q4 Earnings: What's in the Offing?
by Anindya Barman
Celanese's (CE) productivity initiatives and price increase actions are likely to lend support to earnings in Q4.